US Stock MarketDetailed Quotes

XFOR X4 Pharmaceuticals

Watchlist
  • 0.565
  • +0.020+3.71%
Close Jul 3 13:00 ET
  • 0.575
  • +0.011+1.86%
Pre 08:38 ET
94.80MMarket Cap-842P/E (TTM)

X4 Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

X4 Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 7, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.26

-62.50%
Analyst Rating

Strong Buy

Jun 30, 2024

X4 Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.725M--
--2024/Q2-- / 15.265M--
May 7, 20242024/Q10.000 / 0.000--
Mar 21, 20242023/Q40.000 / 0.000--
Nov 9, 20232023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.725M--
--2024/Q2-- / 15.265M--
May 7, 20242024/Q10.000 / 0.000--
Mar 21, 20242023/Q40.000 / 0.000--
Nov 9, 20232023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

X4 Pharmaceuticals Earnings Reports

  • 10-Q: Quarterly report

    May 8 04:31

  • X4 Pharmaceuticals | 10-K: Annual report

    Mar 22 05:13

  • X4 Pharmaceuticals: Q3 2023 Earnings Report

    Nov 10, 2023 06:11

  • X4 Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 11, 2023 04:33

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg